Lidocaine Analgesia For Removal Of Wound Vac Dressings
This study has been completed.
Sponsor:
University of Utah
Information provided by (Responsible Party):
University of Utah
ClinicalTrials.gov Identifier:
NCT01126359
First received: May 17, 2010
Last updated: November 1, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this prospective study is to compare pain levels in patients with topical negative pressure (TNP) dressings removed in a standard manner (i.v. or p.o. pain meds) compared to dressings removed after normal saline or lidocaine is injected retrograde up the suction tube into the foam prior to removal. Our null hypothesis is that there will be no difference in overall pain scores between the groups receiving saline injection and pain medications or just pain medications, compared to those with lidocaine injection and pain medications. Our objective is to disprove this null hypothesis with statistical significance.
| Condition | Intervention |
|---|---|
|
Analgesia |
Drug: Lidocaine Drug: Placebo |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Supportive Care |
| Official Title: | Lidocaine Analgesia For Removal Of Wound Vacuum Assisted Closure Dressings: A Randomized Double Blinded Controlled Trial |
Resource links provided by NLM:
Further study details as provided by University of Utah:
Primary Outcome Measures:
- Visual Analog Scale Pain Score [ Time Frame: 48 hours ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Break-through Narcotic Requirement [ Time Frame: 48 hours ] [ Designated as safety issue: No ]
| Enrollment: | 11 |
| Study Start Date: | August 2008 |
| Study Completion Date: | March 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Placebo Comparator: Saline |
Drug: Placebo
Control dressing change: iv or po pain medication and injection of 0.9% normal saline retrograde up the suction tube.
|
| Active Comparator: Lidocaine |
Drug: Lidocaine
Interventional dressing change: iv or po pain medication with injection of 1% lidocaine retrograde up the suction tube into the sponge.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- wounds to which a split-thickness autologous skin graft applied;
- infected wounds after debridement;
- open fracture wounds;
- acute soft-tissue wounds (with exposed tendon, bone, hardware, and/or joint);
- fasciotomy wounds after compartment syndrome;
- chronic non-healing wounds;
- surgical wounds that are difficult to close due to tension; or
- wounds with external fixation pins or tubes with irritation or drainage.
Exclusion Criteria:
- allergy to lidocaine;
- allergy to the polyurethane foam or impermeable seal;
- malignancy associated with the wound;
- extremity insensate to pain due to any cause (including diabetic neuropathy, or any neurologic disorder therein);
- pregnancy as diagnosed by urine pregnancy test.
Contacts and Locations
More Information
Publications:
| Responsible Party: | University of Utah |
| ClinicalTrials.gov Identifier: | NCT01126359 History of Changes |
| Other Study ID Numbers: | 29398 |
| Study First Received: | May 17, 2010 |
| Last Updated: | November 1, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Utah:
|
Wound Vacuum Assisted Dressings Lidocaine Dressing change Pain management palliative care |
Additional relevant MeSH terms:
|
Lidocaine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses Anti-Arrhythmia Agents Cardiovascular Agents |
ClinicalTrials.gov processed this record on June 18, 2013